Researchers at UAB are studying a new HIV vaccine designed to stimulate strong, targeted immune responses. We are looking for HIV-negative adults ages 18–55 who are in overall good health to participate in this Phase 1 study. Visits include safety checks, blood draws, and scheduled vaccinations.
Compensation is provided for eligible participation.
Call 205-934-7492 or email